1. Investigating the Cause of Noncompliance and Implementing Corrective and Preventive Action (CAPA) Plans Guidance
  2. Exempt Research
  3. De-Identified Publicly Available Datasets Guidance
  4. Evaluating the Scientific or Scholarly Merits of Proposed Research
  5. IRB Composition and Quality Performance
  6. Reporting to Institutional and External Authorities
  7. Review of Data and Safety Monitoring in Research
  8. Changes in Research Activities: Submission and Review
  9. Maintenance of IRB Records
  10. ED/SBS IRB Principal Investigator Responsibilities
  11. Noncompliance
  12. Contact Information for Reporting Suggestions and Concerns
  13. Human Research Protection Program Newsletter
  14. Human Participants Research Training
  15. Good Clinical Practice (GCP) Refresher Instructions
  16. Principal Investigator Status for UW-Madison Studies Involving Human Participants
  17. UW HRPP Quality Assurance
  18. Instructions for Obtaining a Certificate of Confidentiality (CoC)
  19. HRPP Guidance, Forms and Resources
  20. Good Clinical Practice (GCP) Training Frequently Asked Questions
  21. Cross-Campus Human Research Protection Program (HRPP) Committee Charter
  22. IRB Meetings
  23. Use of Human Fetal Tissue in Research
  24. IRB Meeting Minutes and Regulatory Documentation
  25. IRB Purview
  26. Recruitment of Research Participants Guidance
  27. Student Research
  28. ED/SBS IRB Office Guidance Index
  29. IRB Reliance
  30. Review of Research Involving Vulnerable Participants
  31. Obtaining and Documenting Informed Consent
  32. NIH Genomic Data Sharing Policy for Human Data Guidance
  33. Reporting of Suggestions and Concerns Regarding the Protection of Research Participants
  34. OHRP Continuing Review Guidance
  35. FDA IRB Regulations (21 CFR 56)
  36. Expert Review
  37. HRPP Education and Training
  38. IRB Authority and Independence
  39. Instructions for Completing CITI Human Participants Research Training
  40. HRPP and IRB Resources
  41. Office for Human Research Protections (OHRP) - IRB Knowledge of Local Research Context
  42. Institutional Officials in Charge of HRPP
  43. Retention of IRB Records
  44. List of Approved De-Identified Publicly Available Datasets
  45. Continuing Review: Submission and Review
  46. Conflicts of Interest of Non-UW-Madison Key Personnel
  47. Equitable Selection of Research Participants Guidance
  48. Reporting of Suggestions and Concerns Regarding HRPP Performance and Function
  49. OHRP & FDA Expedited Review Guidance
  50. Common Rule (45 CFR 46)
  51. Engagement in Human Participants Research at UW-Madison
  52. Compliance with Human Research Protections in Sponsored Research
  53. Instructions for Linking Previous CITI Training to Your NetID
  54. UW-Madison HIPAA Program
  55. Campus IT Policies
  56. Five Year Replacement/Renewal
  57. IRB Consultants Use and Conflict of Interest
  58. Human Subjects Research Protection Program (HRPP) Policy Index
  59. Suspension and Termination of Approved Research
  60. Reportable Abuse and Neglect Guidance
  61. Compliance Monitoring and Quality Improvement
  62. Unanticipated Problems
  63. OHRP Guidance on Engagement of Institutions in Human Subjects Research
  64. Issues in Human Subjects Research When State Law May Apply
  65. Research with Adult Participants Lacking Capacity to Consent
  66. Monitoring the Consent Process
  67. Preventing Noncompliance Guidance
  68. Study Closure
  69. HRPP Resources for the Public
  70. Use of Human Fetal Tissue in Research Policy Links
  71. IRB Analysis of Risks and Benefits of Research Guidance
  72. OPRR Guidance on 45 CFR 46.101(b)(5): Exemption for Research and Demonstration Projects on Public Benefit and Service Programs
  73. Exceptions to Informed Consent Requirements in Emergency Situations
  74. Single Institutional Review Board (IRB) for Multi-Site Federal Grants Policy
  75. Protecting Research Participants Privacy Interests and Confidentiality of Data
  76. Developing an Internal Quality Assurance (QA) Program Guidance
  77. IRB Review of Study Resources
  78. IRB Members’ Conflicts of Interest
  79. Considerations for Accepting or Ceding IRB Review Guidance
  80. Creation and Dissemination of Policies and Related Documentation
  81. Initial Review: Submission and Review Policy
  82. Post-Approval Monitoring Program
  83. Quality Assurance Committees
  84. Support for Clinical Trials Registration & Results Reporting
  85. Post Approval Monitoring Program Services
  86. Instructions for Completing CITI Refresher Training
  87. UW Post-Approval Monitors
  88. Additional Requirements When Conducting Human Subjects Research with Department of Energy (DOE) Support
  89. Application of Federalwide Assurance (FWA) Terms to UW-Madison Human Participants Research Policy
  90. UW-Madison Federalwide Assurance (FWA)
  91. Additional Requirements When Conducting Human Subjects Research with Department of Defense (DOD) Support
  92. Modification to the IRB Stamp - FAQ
  93. Human Research Protection Program (HRPP) Newsletter - Spring 2017
  94. Human Research Protection Program (HRPP) Newsletter - Fall 2016
  95. Human Research Protection Program (HRPP) Newsletter - Spring 2016
  96. Additional Requirements When Conducting Human Subjects Research with Department of Justice (DOJ) Support
  97. Additional Requirements When Conducting Human Subjects Research with Department of Education (ED) Support
  98. Additional Requirements When Conducting Human Subjects Research with Environmental Protection Agency (EPA) Support
  99. UW Human Research Protection Program Newsletter - Fall 2015